SecBot SecBot
8-K ·Filed May 18, 2026

BSX

BOSTON SCIENTIFIC CORP
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0000885725-26-000042
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The buyback accelerates capital return but provides no new operational information. Monitor the final share count upon June 30 settlement for the exact EPS impact. With $3B remaining authorization, the pace of future execution matters more than this single transaction. The filing.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$55.89
T+0 close · May 18, 2026 · via day close
Latest settled
−8.04%
T+60 · $51.40
Vs SPY
−12.62%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $55.89entry
  2. T+1 · 6mo ago +1.66%α +2.31% · $56.82
  3. T+5 · 6mo ago +3.10%α +1.48% · $57.62
  4. T+20 · 5mo ago −16.33%α −18.52% · $46.76
  5. T+60 · 3mo ago −8.04%α −12.62% · $51.40

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to repurchase its common stock, receiving ~30.4M shares initially (80% of $2B at $52.68 close). The program is part of a previously authorized $5B buyback, with final settlement expected by June 30, 2026. The ASR is expected to add $0.02 to FY2026 adjusted EPS, but the filing provides no other financial data, it is a routine capital allocation announcement with a modest EPS tailwind.

Key Facts

  • $2B accelerated share repurchase agreement with JPMorgan Chase Bank announced May 18, 2026
  • Initial delivery of ~30.4M shares (~80% of $2B at May 15 close of $52.68)
  • Final settlement expected by June 30, 2026; $3B remains under the $5B authorization
  • Expected net impact to FY2026 adjusted EPS is $0.02 accretive to prior guidance

Financial Impact

$2.0 billion ASR with ~30.4 million initial shares; $0.02 accretive to FY2026 adjusted EPS

epsshares outstanding

Risk Factors

  • ASR final share count depends on VWAP during the term, lower price means more shares retired, but that reflects underlying weakness
  • Buyback does not offset operational challenges if future earnings disappoint

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (41 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000885725-26-000042
Exhibit: exhibit991-pressrelease_fi.htm0000885725-26-000042
Document: 0000885725-26-000042-index-headers.html0000885725-26-000042
Document: 0000885725-26-000042-index.html0000885725-26-000042
Document: 0000885725-26-000042.txt0000885725-26-000042

Track record

23 reports on BSX

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 17, 2026today 8-K Neutral 2/10 Entry $43.28 Now $43.03 −0.58% settles Dec 17
  2. Oct 28, 202620d ago 8-K Bearish 6/10 No price data
  3. Oct 28, 202620d ago Press Release Bearish 5/10 Entry $42.43 Now $43.03 −1.41% settles Nov 25
  4. Oct 23, 202625d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.03 +5.82% settles Nov 20
  5. Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.03 +3.49% ▲ +10.20% +11.54% vs SPY
  6. Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.03 +3.56% ▲ +0.25% +0.93% vs SPY
  7. Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $48.08 to $43.65 Now $43.03 −10.50% ▼ −9.21% −9.57% vs SPY
  8. Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 Now $43.03 +10.67% ▲ +9.24% +10.44% vs SPY
  9. Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.03 −12.20% ▼ −8.35% −9.66% vs SPY
  10. Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.03 −14.72% ▼ −10.86% −9.95% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026